// company-profile

Gain Therapeutics, Inc.

GANX
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings40Insiders11
// api This Gain Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for GANX in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Gain Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$13.8M
QoQ change
-41.2%
Reporting period
2026-03-31
#1
MARSHALL WACE, LLP
CIK 1318757
$2.9M
1.5M shares
#2
Potomac Capital Management, Inc.
CIK 1418746
$2.0M
1.0M shares
#3
JONES FINANCIAL COMPANIES LLLP
CIK 815917
$1.2M
632K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Mar 24, 2026Fuggetta GianlucaGANX
Award
50,000$0.00$0K
Mar 24, 2026Mack GeneGANX
Award
200,000$0.00$0K
Jun 24, 2025Islam KhalidGANX
Award
15,000$0.00$0K
Jun 24, 2025GOLDSTEIN DOV A MDGANX
Award
15,000$0.00$0K
Jun 24, 2025Nicaise ClaudeGANX
Award
15,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.